Literature DB >> 2259437

New applications of MR contrast agents in neuroradiology.

G Sze1.   

Abstract

Contrast enhancement has now become an integral part of MR imaging. In this paper, the current uses of contrast agents in MR imaging of both the head and spine are reviewed. In addition, new applications of contrast in MR imaging, including some more current and controversial, are also explored.

Mesh：

Substances：

Year:  1990        PMID： 2259437     DOI： 10.1007/bf00588476

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  34 in total

1.  Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.

Authors:  H P Niendorf; M Laniado; W Semmler; W Schörner; R Felix
Journal:  AJNR Am J Neuroradiol       Date:  1987 Sep-Oct       Impact factor: 3.825

2.  Leptomeningeal metastases: MR evaluation.

Authors:  D M Yousem; P M Patrone; R I Grossman
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

3.  Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction.

Authors:  J H Simon; J Szumowski
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

4.  Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.

Authors:  G Sze; S Bravo; G Krol
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

5.  Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.

Authors:  G K Stimac; B A Porter; D O Olson; R Gerlach; M Genton
Journal:  AJR Am J Roentgenol       Date:  1988-12       Impact factor: 3.959

6.  Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

Authors:  D H Carr; J Brown; G M Bydder; R E Steiner; H J Weinmann; U Speck; A S Hall; I R Young
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

7.  Gadolinium-DTPA in spinal disease.

Authors:  G Sze
Journal:  Radiol Clin North Am       Date:  1988-09       Impact factor: 2.303

8.  MRI in the detection of malignant infiltration of bone marrow.

Authors:  R H Daffner; A R Lupetin; N Dash; Z L Deeb; R J Sefczek; R L Schapiro
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

9.  Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs.

Authors:  G Di Chiro; M E Girton; J A Frank; M J Dietz; O A Gansow; D C Wright; A J Dwyer
Journal:  Radiology       Date:  1986-07       Impact factor: 11.105

10.  Contrast-enhanced MR imaging of malignant brain tumors.

Authors:  M Graif; G M Bydder; R E Steiner; P Niendorf; D G Thomas; I R Young
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825
View more
  1 in total

1.  Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.

Authors:  D Balériaux; C Matos; D De Greef
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.